Prognostic value of the human antigen R (HuR) in human breast cancer: High level predicts a favourable prognosis

Anticancer Research

Volumn 31, Issue 1, 2011, Pages 303-310

  Yuan, Zhu ^a,b   Sanders, Andrew J ^a   Ye, Lin ^a   Wang, Yu ^b   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Histological status; HuR; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; HUR PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; METASTASIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NOTTINGHAM PROGNOSTIC INDEX; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ANTIGENS, SURFACE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 79851498863     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Feigelson HS, Henderson BE and Pike MC: Re: Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 89: 1810-1812, 1997.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
3. Peng SS, Chen CY, Xu N and Shyu AB: RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17: 3461-3470, 1998. (Pubitemid 28279518)
4. Brennan CM and Steitz JA: HuR and mRNA stability. Cell Mol Life Sci 58: 266-277, 2001. (Pubitemid 32217358)
5. Ma WJ, Cheng S, Campbell C, Wright A and Furneaux H: Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271: 8144-8151, 1996. (Pubitemid 26108641)
6. Ma WJ and Furneaux H: Localization of the human HuR gene to chromosome 19p13.2. Hum Genet 99: 32-33, 1997.
7. Yao KM, Samson ML, Reeves R and White K: Gene elav of Drosophila melanogaster. a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J Neurobiol 24: 723-739, 1993. (Pubitemid 23157139)
8. Okano HJ and Darnell RB: A hierarchy of Hu RNA binding proteins in developing and adult neurons. J Neurosci 17: 3024-3037, 1997.
9. Myer VE, Fan XC and Steitz JA: Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J 16: 2130-2139, 1997. (Pubitemid 27170973)
10. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL and Gorospe M: Concurrent versus individual binding of HuR and AUFl to common labile target mRNAs. EMBO J 23: 3092-3102, 2004.
11. Wang W, Caldwell MC, Lin S, Furneaux H and Gorospe M: HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 19: 2340-2350, 2000. (Pubitemid 30259015)
12. Wang W, Yang X, Cristofalo VJ, Holbrook NJ and Gorospe M: Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence. Mol Cell Biol 21: 5889-5898, 2001.
13. Sheflin LG, Zou AP and Spaulding SW: Androgens regulate the binding of endogenous HuR to the AU-rich 3′UTRs of HIF-1 alpha and EGF mRNA. Biochem Biophys Res Commun 322: 644-651, 2004. (Pubitemid 39490351)
14. Esnault S and Malter JS: Hyaluronic acid or TNF-alpha plus fibronectin triggers granulocyte macrophage-colony-stimulating factor mRNA stabilization in eosinophils yet engages differential intracellular pathways and mRNA binding proteins. J Immunol 171: 6780-6787, 2003. (Pubitemid 37532112)
15. Levy NS, Chung S, Furneaux H and Levy AP: Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273: 6417-6423, 1998. (Pubitemid 28144735)
16. Tran H, Maurer F and Nagamine Y: Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol 23: 7177-7188, 2003. (Pubitemid 37211000)
17. Lopez de Silanes I, Zhan M, Lal A, Yang X and Gorospe M: Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 101: 2987-2992, 2004. (Pubitemid 38327723)
18. Lopez de Silanes I, Lal A and Gorospe M: HuR: posttranscriptional paths to malignancy. RNA Biol 2: 11-3, 2005.
19. Lopez de Silanes I, Fan J, Yang X, Zonderman AB, Potapova O, Pizer ES and Gorospe M: Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22: 7146-7154, 2003. (Pubitemid 37378547)
20. Heinonen M, Bono P, Narko K, Chang SH, Lundin J, Joensuu H, Furneaux H, Hla T, Haglund C and Ristimaki A: Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 65: 2157-2161, 2005. (Pubitemid 40490122)
21. Shao W and Brown M: Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res 6: 39-52, 2004. (Pubitemid 38195559)
22. Pryzbylkowski P, Obajimi O and Keen JC: Trichostatin A and 5 Aza-2′ deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR. Breast Cancer Res Treat 114: 15-25, 2008. (Pubitemid 352009220)
23. Ortega AD, Sala S, Espinosa E, Gonzalez-Baron M and Cuezva JM: HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence. Carcinogenesis 29: 2053-2061, 2008.